Overview

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

Status:
Withdrawn
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that treatment of Hereditary Angioedema at the time of prodromal symptoms will decrease morbidity associated with the disease
Phase:
Phase 4
Details
Lead Sponsor:
Penn State University
Treatments:
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein
Complement C1s